Nicolas Brice

Jul 17, 2024 | scirp.org | Nicolas Brice |Adan Garcia |Adán García |Víctor Lomeli |Michael Arnot

1. IntroductionDexamethasone is a corticosteroid commonly used in anti-cancer therapy. For patients who have brain tumors, dexamethasone is used to reduce inflammation caused by the tumor [1] [2]. Studies have shown that many brain cancer patients suffer from epileptic seizures [3]-[6]. Thus, dexamethasone is frequently administrated along with seizure treatment drugs such as phenytoin [7] [8]. Phenytoin has a narrow therapeutic window [9].

Feb 13, 2024 | mondaq.com | Jason Beer |Jürgen Beninca |Nicolas Brice |Serge Clerckx

The Development: On January 24, 2024, the European Commission ("EC") unveiled a package of five fresh initiatives aimed at strengthening the European Union's ("EU") economic security (the "Package"). This will likely increase the walled-garden approach of the EU market with expanded control of inbound investments and possibly also novel restrictions on outbound investments. The Background: Ensuring economic security has recently emerged as a new policy priority for the EU.

Dec 1, 2023 | jdsupra.com | Jason Beer |Jürgen Beninca |Nicolas Brice

Ireland Joins Other European Jurisdictions With Broad FDI RegimesIreland joins a growing number of European jurisdictions with broad foreign direct investment ("FDI") regimes, adding further regulatory complexity to multijurisdictional deals in Europe.

Oct 17, 2023 | jdsupra.com | Jason Beer |Jürgen Beninca |Nicolas Brice

On October 3, 2023, the European Commission ("Commission") unveiled a list of 10 technology areas qualified as "critical" to the European Union's ("EU") economic security, out of which four (Semiconductors, AI, Quantum Technologies, and Biotechnologies) are considered as highly likely to present the most sensitive and immediate risks related to Europe's technology security and technology leakage.

Jul 24, 2023 | jdsupra.com | Jürgen Beninca |Nicolas Brice |Serge Clerckx

In Short The Situation: On July 13, 2023, the European Court of Justice ("ECJ") issued a judgment (Case C-106/22 - Xella) clarifying the conditions under which EU Member States may screen and block foreign direct investments. The Background: Over the past few years, EU Member States have strengthened their national Foreign Direct Investment ("FDI") screening mechanisms and blocked an increasing number of transactions by non-EU investors.